Fumiko Chino

GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History

This cross-sectional study examines how use of glucagon-like peptide-1 (GLP-1) receptor agonists varies among US adults with diabetes with or without a history of cancer.